teva pharmaceutical indust.ltd - pergolide as mesylate 0.25 mg - tablets - pergolide - pergolide is indicated as adjunctive treatment to levodopa/carbidopa in the management of the signs and symptoms of parkinson's disease with on-off phenomena. pergolide is indicated as monotherapy in the initial treatment period of parkinson's disease.
ישראל -
עברית -
Ministry of Health